ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,593Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 113

$380K Total Retail Price of All Prescriptions

Rank: 55 out of 113

399 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 399 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 399 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 6,910 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 388 350 1 1
LISINOPRIL 359 345 2 3
SIMVASTATIN 355 313 3 2
AMLODIPINE BESYLATE 318 314 4 4
OMEPRAZOLE 259 221 5 5
FUROSEMIDE 240 229 6 6
HYDROCHLOROTHIAZIDE 180 175 7 9
ATENOLOL 179 179 8 16
ALENDRONATE SODIUM 172 160 9 22
CITALOPRAM HBR 161 145 10 17
WARFARIN SODIUM 140 133 11 8
HYDROCODONE-ACETAMINOPHEN 137 127 S3 12 7
BENAZEPRIL HCL 128 126 13 46
METOPROLOL SUCCINATE 118 111 14 10
METOPROLOL TARTRATE 116 105 15 14
LOSARTAN POTASSIUM 107 106 16 13
PRAVASTATIN SODIUM 107 96 16 23
ATORVASTATIN CALCIUM 103 100 18 15
POTASSIUM CHLORIDE 101 96 19 12
METFORMIN HCL 96 88 20 11
SERTRALINE HCL 81 67 21 21
DETROL LA 76 42 22 128
FLUOXETINE HCL 72 41 23 31
PAROXETINE HCL 71 56 24 45
METFORMIN HCL ER 70 67 25 51
GLIMEPIRIDE 70 58 25 36
DIGOXIN 66 66 27 27
LOVASTATIN 65 65 28 53
DIOVAN 64 64 29 42
PREDNISONE 60 60 30 28
DONEPEZIL HCL 58 58 31 33
TERAZOSIN HCL 54 49 32 106
GABAPENTIN 51 51 33 18
PANTOPRAZOLE SODIUM 50 50 34 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.